Compound Summary
N-Acetyltryptamine
Compound Information
N-Acetyltryptamine
Compound Name: | N-Acetyltryptamine |
Compound CID: | 70547 |
Synonyms: | N-Acetyltryptamine 1016-47-3 N-2-(1H-Indol-3-yl)ethylacetamide N-(2-(1H-indol-3-yl)ethyl)acetamide Acetotryptamide More... |
Iupac Name: | N-[2-(1H-indol-3-yl)ethyl]acetamide |
InChI: | InChI=1S/C12H14N2O/c1-9(15)13-7-6-10-8-14-12-5-3-2-4-11(10)12/h2-5,8,14H,6-7H2,1H3,(H,13,15) |
InChIKey: | NVUGEQAEQJTCIX-UHFFFAOYSA-N |
Canonical Smiles: | CC(=O)NCCC1=CNC2=CC=CC=C21 |
Isomeric Smiles: | CC(=O)NCCC1=CNC2=CC=CC=C21 |
Molecular Weight: | 202.25 |
Molecular Formula: | C12H14N2O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
N-Acetyltryptamine
Molecular Weight: | 202.25 |
Molecular Formula: | C12H14N2O |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 15 |
Complexity: | 230 |
Synonyms
N-Acetyltryptamine
| N-Acetyltryptamine | N-Acetyltryptamine |
|---|---|
N-Acetyltryptamine |
1016-47-3 |
N-2-(1H-Indol-3-yl)ethylacetamide |
N-(2-(1H-indol-3-yl)ethyl)acetamide |
Acetotryptamide |
Acetamide, N-2-(1H-indol-3-yl)ethyl- |
3-(2-N-Acetylaminoethyl)indole |
MFCD00209910 |
CHEMBL33171 |
N-2-(1H-Indol-3-yl)-ethyl-acetamide |
CHEBI:55515 |
Acetamide, N-(2-(1H-indol-3-yl)ethyl)- |
N-Acetyltryptamine; N10-Acetyltryptamine; Nb-Acetyltryptamine; Nomega-Acetyltryptamine |
SMR000686036 |
SR-01000075685 |
Nb-acetyltryptamine |
Acetamide, N-(2-indol-3-ylethyl)- |
Tocris-0357 |
Lopac-A-7342 |
N-Acetyltryptamine, powder |
3-(2-Acetamidoethyl)indole |
Lopac0_000101 |
MLS001250169 |
MLS002153204 |
SCHEMBL468850 |
ISUPSL100255 |
ACon1_000465 |
N-(2-indol-3-ylethyl)acetamide |
DTXSID30144042 |
HMS2270O21 |
HMS3260E04 |
HMS3266I05 |
HMS3411G05 |
HMS3675G05 |
ZINC174849 |
BAA01647 |
Tox21_500101 |
0428AA |
BDBM50282758 |
PDSP1_001815 |
PDSP2_001798 |
STL352108 |
AKOS000639631 |
CCG-204196 |
LP00101 |
MCULE-3484861085 |
SDCCGSBI-0050089.P002 |
NCGC00015088-01 |
NCGC00015088-02 |
NCGC00015088-03 |
NCGC00015088-04 |
NCGC00015088-05 |
NCGC00015088-06 |
NCGC00015088-07 |
NCGC00015088-08 |
NCGC00015088-09 |
NCGC00024552-01 |
NCGC00024552-02 |
NCGC00024552-03 |
NCGC00024552-04 |
NCGC00024552-05 |
NCGC00024552-06 |
NCGC00260786-01 |
AS-63601 |
N-2-(1H-Indol-3-yl)ethylacetamide # |
B6274 |
EU-0033445 |
EU-0100101 |
ST50409166 |
A 7342 |
N17090 |
Acetamide, N-(2-indol-3-ylethyl)- (7CI,8CI) |
Acetotryptamide N-Acetyl-2-(indol-3-yl)ethylamine |
Acetamide, N-2-(1H-indol-3-yl)ethyl- (9CI) |
J-000457 |
SR-01000075685-1 |
SR-01000075685-2 |
SR-01000075685-4 |
BRD-K73700643-001-04-7 |
BRD-K73700643-001-10-4 |
Q27124335 |
2-(n,n-dimethyliminium)-4-ethyl-5-mercapto-1,3-dithiol,innersalt |
NCGC00015088-09_C12H14N2O_N-2-(1H-Indol-3-yl)ethylacetamide |
374572-55-1 |
7AN |
Experimental Data
N-Acetyltryptamine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -2.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
N-Acetyltryptamine
Statistics Data
N-Acetyltryptamine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -2.000000000000000 | 1 | 1 |
Statistics Data Visualization
N-Acetyltryptamine
